Laryngeal squamous cell carcinoma molecular marker hsa_circ_0004547 and detection method and application thereof
A molecular marker, laryngeal squamous cell carcinoma technology, applied in biochemical equipment and methods, microbial determination/inspection, medical preparations containing active ingredients, etc., can solve problems such as off-target effects and unreasonable design, and achieve detection efficiency high effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0045] A detection method and application of the molecular marker hsa_circ_0004547 and its expression in laryngeal squamous cell carcinoma.
[0046] A molecular marker for laryngeal squamous cell carcinoma. The molecular marker for laryngeal squamous cell carcinoma is hsa_circ_0004547, and its genome location is: chr22:29517344-29521404. The nucleotide sequence of hsa_circ_0004547 is shown in SEQ ID NO:1.
[0047] The expression level of hsa_circ_0004547 in laryngeal cancer patients is up-regulated. The malignancy of laryngeal squamous cell carcinoma is correlated with the hsa_circ_0004547 molecular expression, the higher the malignancy, the higher the hsa_circ_0004547 molecular expression.
[0048] The laryngeal squamous cell carcinoma molecular marker hsa_circ_0004547 is used in the preparation of an auxiliary diagnostic kit for laryngeal squamous cell carcinoma.
[0049] A method for detecting the expression level of the laryngeal cancer molecular marker hsa_circ_0004547, co...
Embodiment 2
[0079] The siRNA of hsa_circ_0004547 was synthesized by using the laryngeal cancer molecular marker hsa_circ_0004547 of the present invention.
[0080] First, siRNA for hsa_circ_0004547 was synthesized.
[0081] According to the siRNA design principle, the synthetic siRNA sequence contains the circularization site of the circular RNA, and the sequence with a fragment length of 20 bp is used as the candidate target sequence. By comparing the human genome sequence, it is ensured that there is no homologous sequence. The siRNA designed in the present invention The sequence is as follows:
[0082] Sense strand: 5'-UCUUUGAUAUGCCUGGAAA-3'
[0083] Antisense strand: 5'-UUUCCAGGCAUAUCAAAGA-3'
[0084] Send the sequence to Suzhou Gemma Company for synthesis, add two deoxyribonucleic acid dTdT, increase the stability of siRNA, and label siRNA with green fluorescence.
[0085] Second, siRNA transfection was performed on laryngeal squamous cell carcinoma cells.
[0086] Laryngeal squa...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com